Will Preventive HIV Vaccine Efficacy Trials Be Possible With Female Injection Drug Users?

Willingness to participate in HIV-1 vaccine trials among young Thai men

“…[1][2][3][4][5][6][7][8][9][10] Besides providing estimates of interest, assessing willingness may identify conditions which foster or inhibit the motivation to join trials, as well as identify important population diVerences. Thailand is one of several countries where preparations for HIV-1 vaccine eYcacy trials have been under way and a number of studies of willingness to participate in trials have taken place.…”

Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention

“…The sample size of Whites from earlier studies spanning from 1994-2000 was higher: IDU (37-65%) 34,[38][39][40] ; MSM (68-95%) 33,34,38,[41][42][43] ; and WAHR-IDU (44%). 34 However, an exception to the results of these earlier studies was one study in WAHR in 1998, which consisted of 18% Whites.…”

Socioeconomic status and HIV vaccine preparedness studies in North America

“…In one study in MSM that stratified by age, 88.5% of young men and 89.9% of older men had a >HS educational level [17]. In IDU including methadone maintenance patients, those with a <HS educational level ranged from 37% to 74% [11,13,15,18,19]; in WAHR, the range was 47% to 49% [15,20]; in WAHR-IDU, 34% had <HS educational level [15].…”

“…In studies in IDU, there was in large part no statistically significant relationship between educational level and WTP [11,18,19,28]. In one Canadian study in IDU, a ≥HS educational level was positively related to WTP (AOR = 1.96, 95% CI = 1.07-3.59) [11].…”